Skip to main content
REMICADE 100 mg/10mL injection, powder, lyophilized, for solution by Janssen Biotech, Inc.
REMICADE, 100 mg/10mL, injection, powder, lyophilized, for solution Drug class: Tumor Necrosis Factor Blocker. Available on prescription only. Listed by Janssen Biotech, Inc..
Prescription only

REMICADE

INFLIXIMAB

Listed by Janssen Biotech, Inc.

Strength
100 mg/10mL
Form
Injection, Powder, Lyophilized, For Solution
Route
Intravenous
Class
Tumor Necrosis Factor Blocker

What it contains

  • Infliximab 100 mg/10mL

FDA record

Dosage form Injection, Powder, Lyophilized, For Solution
Route Intravenous
Drug class Tumor Necrosis Factor Blocker
Approval route BLA — biologic licence
NDC code 57894-030
FDA application BLA103772
RxNorm concept 213361
Package sizes listed 1
Marketed since August 1998

Other products containing Infliximab

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

AVSOLA

infliximab-axxq

Strength
100 mg/10mL
Form
Injection, Powder, Lyophilized, For Solution
Class
Tumor Necrosis Factor Blocker
Rx only

Amgen, Inc

$23,100.00 We supply Infimab 100 mg View product

INFLECTRA

infliximab-dyyb

Strength
100 mg/10mL
Form
Injection, Powder, Lyophilized, For Solution
Class
Tumor Necrosis Factor Blocker
Rx only

Pfizer Laboratories Div Pfizer Inc

$23,100.00 We supply Infimab 100 mg View product

INFLIXIMAB

Strength
100 mg/10mL
Form
Injection, Powder, Lyophilized, For Solution
Class
Tumor Necrosis Factor Blocker
Rx only

Janssen Biotech, Inc.

$23,100.00 We supply Infimab 100 mg View product

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.